We found that CaaX‐1 has a different impact on KRas signaling and KRas regulators in the two pancreatic cancer cell lines tested, suggesting specificity with respect to the KRas‐mutated PANC‐1 cells. This evidence concerns the gene KRAS and pancreatic neoplasm.